GILTERITINIB vs GLICLAZIDE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
GILTERITINIB vs GLICLAZIDE: Safety Overview
| Metric | GILTERITINIB | GLICLAZIDE |
|---|---|---|
| Total FAERS Reports | 3,672 | 5,784 |
| Deaths Reported | 1,014 | 483 |
| Death Rate | 27.6% | 8.4% |
| Hospitalizations | 1,407 | 3,195 |
| Average Patient Age | 60.8 yrs | 65.0 yrs |
| % Female Patients | 48.5% | 55.2% |
| FDA Approval Date | Nov 28, 2018 | N/A |
| Manufacturer | Astellas Pharma US, Inc. | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | N/A |